Programme Advisory Committee:
Senior Adviser, National Institute of Pharmacy Directorate of the National Institute for Quality- and Organizational Development in Healthcare and Medicines and Professor at the Institute of Drug Regulatory Affairs, University of Szeged, Hungary
Prof. Tamás L. Paál holds a degree in Pharmacy and Chemical Engineering. After spending eleven years in the Hungarian pharmaceutical industry Prof. Paál joined the National Institute of Pharmacy, the Hungarian competent agency for human medicines. Prof. Paál was Director-General of the Agency for 23 years. Having reached the age of 65 when such appointments expire in Hungary, he performs an advisory role in the capacity of President of the Scientific Board to the same Agency. Prof. Paál is also part-time professor at the University of Szeged, Hungary, teaching regulatory affairs and quality assurance.
Professor Tomasz Twardowski, President of the Polish Biotechnology Federation (PFB)
Prof. Tomasz Twardowski is the president of the Polish Biotechnology Federation and a researcher who has spent the last few years promoting the achievements of genetic engineering in Poland. He is also heavily engaged in legal and social issues related to biotechnology, including intellectual property rights, biosafety and social acceptance. He has been conducting research at the PAN Institute of Bioorganic Chemistry in Poznan„ since 1974, and in 1995 also began working at the Technical University of Lódz's Institute of Technical Biochemistry. He has written more than 70 original experimental papers, in addition to over 100 communiqués, 100-odd overviews, and 150 or so articles. He has authored, co-authored and edited over 30 books. Prof. Twardowski has represented Poland in the work of biotechnology teams set up by the United Nations Environment Program (UNEP) and the Organization for Economic Cooperation and Development (OECD). He is a member of Poland's Central Commission for Academic Titles and Degrees (1997-2009), and vice-chairman of the Biotechnology Committee (1991-2009).
Professor Ádám Vas, M.D., Ph.D., Senior Research Adviser, Gedeon Richter Plc Budapest, Hungary
Professor Vas holds a degree in medicine and clinical pharmacology. He got his PhD degree in the pharmacogenetic background of hepatic drug metabolism. Dr. Vas is part-time Professor at the Szeged University, I. Department of Medicine teaching clinical pharmacology. He is officer of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Head of the Scientific-Engineering Committee of the Hungarian Pharmaceutical Manufacturers Association, Leader of the Hungarian Innovative Medicines Technological Platform and member of the EU Innovative Medicines Initiative Scientific Committee among other positions.
Theodore Iliopoulos, Vice President of the Management Board, Polpharma
Theodore Iliopoulos graduated from the University of Athens as a Chemist and has an impressive thirty seven-year career in Pharmaceutical Operations, first working for 13 years for Greek national companies before joining Bristol Myers Squibb in 1986 in a key Quality Assurance position. He was rapidly promoted in BMS into site management roles and then into multi site responsibilities, first having the European plants reporting to him and finally he was responsible for all BMS plants in the Americas as VP Manufacturing of the Americas. In 2002, after 15 years service with BMS, he joined Polpharma as Chief Operating Officer where he gained a tremendous understanding of the functioning of all aspects of the generic pharmaceutical industry and the health care sector in general in Eastern Europe. In 2004 he moved to Patheon, a leading global contract manufacturing and development services organization, where he spend 2 years as VP Operations Europe before rejoining Polpharma in his previous role. At Polpharma he is responsible for the industrial operations (infrastructure, supply chain, engineering, production) and for the Fine Chemicals Business Unit.
Prof. Dr. Vladimír Král, Director of Chemical Development, Zentiva, a member of the sanofi-aventis Group
Professor Král holds a degree in organic chemistry and received his PhD degree in organic chemistry and biochemistry. Between 1995 - 2005 he held the position of Professor of Analytical Chemistry at the Technical University of Prague, Czech Republic, conducting research on sensor analysis, supramolecular chemistry, bioanalytical chemistry and biosensors. Between 2000-2004 Professor Král was a visiting professor in the department of chemistry and biochemistry at the University of Texas in Austin, USA, where he focused on aniuon sensors, drug development, texaphyrins and pharmacylic. Between 2000 - 2005 he also spent two months each year as a visiting professor at the medical school of the University of Texas in San Antonio, USA, focusing on selective NOS inhibitors. Since 2005 he has held his current position of Director of Chemical Development at Zentiva in the Czech Republic.
Dr. Sergii Sur, R&D Director, Arterium Corporation
Dr. Sur has over 25 years of work experience in the pharmaceutical market, including 14 years in management positions. He received his PhD degree in Pharmacy and published about 100 scientific publications. Between 1993 and 1998 he was the Head of State Laboratory for Quality Control of Medicines at the Institute of Pharmacology and Toxicology at the Ukrainian Academy of Medical Sciences in Kiev. Between 1998 and 2005 he was working for the Ukraine Ministry of Health, first as the Director of Central Laboratory for Quality Control of Medicines and since 2000 as the Deputy Chief Inspector for Quality Control of Medicines. Since 2005 Dr. Sur is in his current position responsible for the development of a functional strategy in R&D; the development and introduction of R&D business processes and structure; and the organization of research, development and registration of new products. Additionally Dr. Sur is a member of the International Federation of Pharmacists (FIP) and since 1998 an adviser on International Pharmacopoeia and Pharmaceutical Preparations and since 2002 also on Traditional Medicines for the WHO headquarter in Geneva.
Ernő Duda, President and CEO, SOLVO Biotechnology & President of the Hungarian Biotechnology Association (HBA)
Ernő Duda received his degree in management studies at the Euro-Contact Business School in Budapest and started his career as the founder and CEO of Copy General, Hungary, which became the largest chain of photocopiers in Hungary. In 1996 he founded LP Invest, a corporate finance consulting company which focused on start-ups in lifescience and IT-sector. As the Managing Director he negotiated and concluded several high-tech investment deals. In 1999 Ernő Duda founded SOLVO Biotechnology which became the largest independent biotech company in Hungary with clients including the top 20 international pharma and biotech companies. As President and CEO of SOLVO Biotechnology he managed several VC investments. In 2002 Ernő Duda founded the Hungarian Biotechnology Association and with his team of experts he developed the Hungarian government's five-year, national biotechnology strategy. He also initiated and manages the "BioManager", a one-year training programme for young scientists interested in the business aspects of life-sciences. In 2009 Ernő Duda received the Honorary Associate Professor title granted by the University of Szeged for his significant input into higher education.
István Király, Senior Manager of Quality Assurance, GSK Biologicals
István Király graduated from the Technical University in Budapest as a mechanical engineer. During his professional career he has filled several technical- and production-related management positions in different industries at large international companies such as General Electric, DANONE, Alcoa and GlaxoSmithKline. These challenges allowed him to be involved in the implementation and operation of different management and quality systems such as ISO, HACCP, GMP, Toyota Production System, Six Sigma and Lean Sigma. In 2006 he joined the company GSK Biologicals Kft. located in Gödöllő, Hungary as Technical Services Senior Manager. He was responsible for maintenance, calibration and investment projects, Energy Management, Validation and EHSS in this position. Within the first year István Király successfully reorganized the technical services, turning it into a customer- and quality-focused organization ensuring the robust operation of the site. Recently, he was appointed to the QA Senior Manager position at the Gödöllő site.
Dr. Péter Lakatos, Member of the Presidency, Hungarian Logistics Association (HLA)
Dr. Péter Lakatos is a certificated economist and Leader in Military Logistics. Between 1983 and 1997 he worked in different positions at the Military of the Hungarian Home Defence Forces. Between 1997 and 2002 he held several positions at Tesco Global Stores Plc. and started as a Training and Stuffing Director. Later he became the 3PL Manager and was responsible for the non-food distribution and was involved in the introduction of cross-docking under an outsourcing contract. Later he held the position as the Director of the public bonded warehouse of Menlo Worldwide Hungary Ltd. and Managing Director of Den Hartogh Ltd.
Currently Dr. Péter Lakatos is the Head of the TEVA Logistic Centre at TEVA Hungary Plc. in Hungary. In addition he is an Associate Professor at the College of Szolnok, guest speaker and instructor at the Selye János University, the Budapest College of Management and the Budapest College of Communication and Business. Between 2006 -2011 Dr. Péter Lakatos was the Vice-President of HLA, issued more than 30 publications and was chairman at several conferences.